These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 10116119)
41. A 30-year trend: what chief pharmacists think about detailers. Teplitsky B Pharm Times; 1985 Nov; 51(11):83-92. PubMed ID: 10274691 [No Abstract] [Full Text] [Related]
42. Pyxis expands role by buying firm. Scott L Mod Healthc; 1995 Jun; 25(26):30. PubMed ID: 10143734 [No Abstract] [Full Text] [Related]
43. The effectiveness of pharmaceutical promotion to hospital pharmacists. Demeritt GA Am J Hosp Pharm; 1966 Jan; 23(1):13-23. PubMed ID: 5901349 [No Abstract] [Full Text] [Related]
44. Competition of high-priced new drugs holds down prices of older drugs. Hosp Purch Manage; 1982 May; 7(5):14-5. PubMed ID: 10255154 [No Abstract] [Full Text] [Related]
45. Achieving provider support of pharmacy benefit design. Navarro RP Med Interface; 1995 Aug; 8(8):80-1, 84. PubMed ID: 10144776 [No Abstract] [Full Text] [Related]
46. Exert your power to ensure that oral solids are visually identifiable. Davis NM Hosp Pharm; 1979 Apr; 14(4):180. PubMed ID: 10240903 [No Abstract] [Full Text] [Related]
47. Hospital pharmacists' attitudes towards medical services representatives: a comparison of directors, staff, and clinical pharmacists. McGhan W; Seery S; Hill B; Koda R Hosp Formul; 1982 Jul; 17(7):957-61. PubMed ID: 10256042 [No Abstract] [Full Text] [Related]
48. When doses disappear. Flu shot shortage sheds light on drug supply chain. Becker C Mod Healthc; 2004 Oct; 34(42):16. PubMed ID: 15552188 [No Abstract] [Full Text] [Related]
49. Marketplace. How drug company mergers affect HMOs and hospitals. Moskowitz DB Faulkner Grays Med Health; 1997 Jun; 51(23):suppl 2 p.. PubMed ID: 10167794 [No Abstract] [Full Text] [Related]
50. Drug price inflation slows but competition is limited. Hosp Purch Manage; 1983 Aug; 8(8):13-4. PubMed ID: 10261667 [No Abstract] [Full Text] [Related]
51. A 25-year trend: what chief pharmacists think about detailmen. Teplitsky B Pharm Times; 1980 Dec; 46(12):55-64. PubMed ID: 10249198 [No Abstract] [Full Text] [Related]
52. Bristol-Myers Squibb drug information department services. Sylvan L; Palmer-Shevlin N Hosp Pharm; 1995 Jan; 30(1):38-9, 44. PubMed ID: 10139729 [TBL] [Abstract][Full Text] [Related]
53. Preparing for prospective payment policies. Nash DB Med Mark Media; 1985 Aug; 20(8):10-1. PubMed ID: 10273664 [No Abstract] [Full Text] [Related]
54. Leading 1994 dollar volume pharmaceuticals. Ramspacher S Hosp Pharm; 1995 Aug; 30(8):666-9, 673. PubMed ID: 10144644 [No Abstract] [Full Text] [Related]
55. Directory of pharmacy service directors of primary medical school hospitals. Davis NM Hosp Pharm; 1979 Apr; 14(4):201-6, 211-6. PubMed ID: 10297416 [No Abstract] [Full Text] [Related]
57. The prescription drug marketing act: a solution in search of a problem? Angarola RT; Beach JE Food Drug Law J; 1996; 51(1):21-55. PubMed ID: 11794352 [No Abstract] [Full Text] [Related]
58. The potential for self-interested behavior by pharmaceutical manufacturers through vertical integration with pharmacy benefit managers: the need for a new regulatory approach. Mitchell EL Food Drug Law J; 1999; 54(1):151-83. PubMed ID: 11758556 [No Abstract] [Full Text] [Related]
59. Manufacturers of hospital pharmacy equipment and supplies. Northern RE; Brown TR Am J Hosp Pharm; 1973 Nov; 30(11):1038-49. PubMed ID: 4584474 [No Abstract] [Full Text] [Related]